Christine Decanter

Lille, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Pre-treatment AMH levels suggesting PCOM do not prevent chemotherapy-induced ovarian damage despite higher long-term ovarian reserve: a longitudinal study in 467 women treated with alkylating agents.

Pre-treatment AMH levels suggesting PCOM do not prevent chemotherapy-induced ovarian damage despite higher long-term ovarian reserve: a longitudinal study in 467 women treated with alkylating agents.

Journal: Human reproduction (Oxford, England)

Published: April 01, 2026

Gestational diabetes mellitus in women with polycystic ovary syndrome.

Gestational diabetes mellitus in women with polycystic ovary syndrome.

Journal: Diabetes & metabolism

Published: January 19, 2026

BrECADD and fertility: an ongoing concern.

BrECADD and fertility: an ongoing concern.

Journal: The Lancet. Oncology

Published: August 01, 2025

Fertility preservation for trans men: Barriers and motivations

Fertility preservation for trans men: Barriers and motivations

Journal: Gynecologie, obstetrique, fertilite & senologie

Published: July 01, 2025

Time-to-pregnancy in patients with previous breast cancer and unexposed women: a prospective exposed-unexposed cohort study.

Time-to-pregnancy in patients with previous breast cancer and unexposed women: a prospective exposed-unexposed cohort study.

Journal: EClinicalMedicine

Published: January 21, 2025

AMH decline during chemotherapy reflects breast cancer cell DNA damage response (DDR) proficiency: the ONCO AMH1 pilot study.

AMH decline during chemotherapy reflects breast cancer cell DNA damage response (DDR) proficiency: the ONCO AMH1 pilot study.

Journal: Journal of assisted reproduction and genetics

Published: December 09, 2024

Sociodemographic profile of women seeking elective egg freezing when financed by the public healthcare system.

Sociodemographic profile of women seeking elective egg freezing when financed by the public healthcare system.

Journal: Reproductive biomedicine online

Published: August 07, 2024

Evaluation of Satisfaction With a Secure, Connected Mobile App for Women in Assisted Reproductive Technology Programs: Prospective Observational Study.

Evaluation of Satisfaction With a Secure, Connected Mobile App for Women in Assisted Reproductive Technology Programs: Prospective Observational Study.

Journal: JMIR human factors

Published: July 12, 2024

Is there a relationship between tumour aggressiveness and ovarian stimulation outcomes in adolescent and young adult patients with lymphoma?

Is there a relationship between tumour aggressiveness and ovarian stimulation outcomes in adolescent and young adult patients with lymphoma?

Journal: Reproductive biomedicine online

Published: April 25, 2024

Folliculogenesis resumption after ovarian cortex transplantation: what is the earliest hormonal indicator?

Folliculogenesis resumption after ovarian cortex transplantation: what is the earliest hormonal indicator?

Journal: Archives of gynecology and obstetrics

Published: March 04, 2024

Pulsatile gonadotropin-releasing hormone therapy: comparison of efficacy between functional hypothalamic amenorrhea and congenital hypogonadotropic hypogonadism.

Pulsatile gonadotropin-releasing hormone therapy: comparison of efficacy between functional hypothalamic amenorrhea and congenital hypogonadotropic hypogonadism.

Journal: Fertility and sterility

Published: February 29, 2024

Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation?

Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation?

Journal: Reproductive biology and endocrinology : RB&E

Published: February 19, 2024

Showing 1-12 of 64

Last Updated: 09/26/2026